Article Text
Abstract
In this article, we discuss the ethical dimensions for the prescribing behaviours of opioids for a chronic pain patient, a scenario commonly witnessed by many physicians. The opioid epidemic in the USA and Canada is well known, existing since the late 1990s, and individuals are suffering and dying as a result of the easy availability of prescription opioids. More recently, this problem has been seen outside of North America affecting individuals at similar rates in Australia and Europe. We argue that physicians are also confronted with an ethical crisis where a capitalist-consumerist society is contributing to this opioid crisis in which societal, legal and business interests push physicians to overprescribe opioids. Individual physicians often find themselves unequipped and unsupported in attempts to curb the prescribing of opioid medications and balance competing goals of alleviating pain against the judicious use of pain medications. Physicians, individually and as a community, must reclaim the ethical mantle of our profession, through a more nuanced understanding of autonomy and beneficence. Furthermore, physicians and the medical community at large have a fiduciary duty to patients and society to play a more active role in curbing the widespread distribution of opioids in our communities.
- pain management
- autonomy
- professional - professional relationship
- applied and professional ethics
- drugs and drug industry
Statistics from Altmetric.com
Footnotes
Contributors Both listed authors contributed to the planning, conduct, writing and editing of this manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No relevant data to be shared.
Patient consent for publication Not required.
Read the full text or download the PDF:
Other content recommended for you
- Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation
- Predicting opioid use disorder in patients with chronic pain who present to the emergency department
- One prescription for the opioid crisis: require buprenorphine waivers for pain medicine fellows
- Effect of a targeted quality improvement education on opioid prescribing
- ‘First Do No Harm’: physician discretion, racial disparities and opioid treatment agreements
- Using electronic health record’s data to assess daily dose of opioids prescribed for outpatients with chronic non-cancer pain
- Evaluation of a state law on opioid-prescribing behaviour and the void affecting codeine-containing antitussive syrup
- Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review
- State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA
- Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine